Page last updated: 2024-10-24

bupivacaine and Cerebrovascular Moyamoya Disease

bupivacaine has been researched along with Cerebrovascular Moyamoya Disease in 2 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, HJ1
Kim, JA1
Lee, JJ1
Kim, HS1
Shin, HJ1
Chung, IS1
Kim, JK1
Gwak, MS1
Choi, SJ1
Jabbour, H1
Jabbour, K1
Ayoub, EN1
Yazbeck, P1
Antakly, MC1

Trials

1 trial available for bupivacaine and Cerebrovascular Moyamoya Disease

ArticleYear
Effect of preoperative skull block on pediatric moyamoya disease.
    Journal of neurosurgery. Pediatrics, 2008, Volume: 2, Issue:1

    Topics: Adolescent; Anesthetics, Inhalation; Bupivacaine; Carbon Dioxide; Cerebrovascular Circulation; Child

2008

Other Studies

1 other study available for bupivacaine and Cerebrovascular Moyamoya Disease

ArticleYear
[Spinal anaesthesia and Moya Moya disease].
    Annales francaises d'anesthesie et de reanimation, 2004, Volume: 23, Issue:5

    Topics: Adolescent; Anesthesia, Spinal; Anesthetics, Local; Blood Pressure; Bupivacaine; Carbon Dioxide; Cer

2004